Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device

Raveen Rathnasinghe, Robert F. Karlicek Jr., Michael Schotsaert, Mattheos Koffas, Brigitte Arduini, Sonia Jangra, Bowen Wang, Jason L. Davis, Mohammed Alnaggar, Anthony Costa, Richard Vincent, Adolfo Garcia-Sastre, Deepak Vashishth, Priti Balchandani
doi: https://doi.org/10.1101/2020.10.05.20206953
Raveen Rathnasinghe
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert F. Karlicek Jr.
6Smart Lighting Engineering Research Center, Rensselaer Polytechnic Institute, Troy NY 12180
7Department of Electrical Computer and Systems Engineering, Rensselaer Polytechnic Institute, Troy NY 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schotsaert
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
5Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mattheos Koffas
8Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180
9Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 1218
10Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, NY 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte Arduini
8Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180
9Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 1218
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia Jangra
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bowen Wang
9Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 1218
14Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason L. Davis
9Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 1218
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed Alnaggar
11Department of Civil and Environmental Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Costa
12Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, 10029
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Vincent
13Department of Medicine, Section of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adolfo Garcia-Sastre
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
3Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029
4The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029
5Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepak Vashishth
9Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 1218
14Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: priti.balchandani@mssm.edu vashid@rpi.edu
Priti Balchandani
15Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: priti.balchandani@mssm.edu vashid@rpi.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Particulate respirators such as N95 masks are an essential component of personal protective equipment (PPE) for front-line workers. This study describes a rapid and effective UVC irradiation system that would facilitate the safe re-use of N95 respirators and provides supporting information for deploying UVC for decontamination of SARS-CoV-2 during the COVID19 pandemic.

Objective To assess the inactivation potential of the proposed UVC germicidal device as a function of time by using 3M® 8211 - N95 particulate respirators inoculated with SARS-CoV-2.

Design A germicidal UVC device to deliver tailored UVC dose was developed and snippets (2.5cm2) of the 3M-N95 respirator were inoculated with 106 plaque-forming units (PFU) of SARS-CoV-2 and were UV irradiated. Different exposure times were tested (0-164 seconds) by fixing the distance between the lamp (10 cm) and the mask while providing an exposure of at least 5.43 mWcm-2.

Setting The current work is broadly applicable for healthcare-settings, particularly during a pandemic such as COVID-19.

Participants Not applicable.

Main Outcome(s) and Measure(s) Primary measure of outcome was titration of infectious virus recovered from virus-inoculated respirator pieces after UVC exposure. Other measures included the method validation of the irradiation protocol, using lentiviruses (biosafety level-2 agent) and establishment of the germicidal UVC exposure protocol.

Results An average of 4.38×103 PFUml-1(SD 772.68) was recovered from untreated masks while 4.44×102 PFUml-1(SD 203.67), 4.00×102 PFUml-1(SD 115.47), 1.56×102 PFUml-1(SD 76.98) and 4.44×101 PFUml-1(SD 76.98) was recovered in exposures 2s,6s,18s and 54 seconds per side respectively. The germicidal device output and positioning was monitored and a minimum output of 5.43 mWcm-2 was maintained. Infectious SARS-CoV-2 was not detected by plaque assays (minimal level of detection is 67 PFUml-1) on N95 respirator snippets when irradiated for 120s per side or longer suggesting 3.5 log reduction in 240 seconds of irradiation.

Conclusions and Relevance A scalable germicidal UVC device to deliver tailored UVC dose for rapid decontamination of SARS-CoV-2 was developed. UVC germicidal irradiation of N95 snippets inoculated with SARS-CoV-2 for 120s per side resulted in 100% (3.5 log in total) reduction of virus. These data support the reuse of N95 particle-filtrate apparatus upon irradiation with UVC and supports use of UVC-based decontamination of SARS-CoV-2 virus during the COVID19 pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was partly funded by CRIP (Center for Research for Influenza Pathogenesis), a NIAID supported Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C); by the generous support of the JPB Foundation, the Open Philanthropy Project (research grant 2020-215611 (5384)), anonymous donors to AG-S, funds from Rensselaer Polytechnic Institute and NIH (5UL1TR001433).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The reported finding did not involve research on human subjects.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data can be made available through email request to the corresponding author, Dr. Priti Balchandani.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device
Raveen Rathnasinghe, Robert F. Karlicek Jr., Michael Schotsaert, Mattheos Koffas, Brigitte Arduini, Sonia Jangra, Bowen Wang, Jason L. Davis, Mohammed Alnaggar, Anthony Costa, Richard Vincent, Adolfo Garcia-Sastre, Deepak Vashishth, Priti Balchandani
medRxiv 2020.10.05.20206953; doi: https://doi.org/10.1101/2020.10.05.20206953
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device
Raveen Rathnasinghe, Robert F. Karlicek Jr., Michael Schotsaert, Mattheos Koffas, Brigitte Arduini, Sonia Jangra, Bowen Wang, Jason L. Davis, Mohammed Alnaggar, Anthony Costa, Richard Vincent, Adolfo Garcia-Sastre, Deepak Vashishth, Priti Balchandani
medRxiv 2020.10.05.20206953; doi: https://doi.org/10.1101/2020.10.05.20206953

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (524)
  • Anesthesia (125)
  • Cardiovascular Medicine (1432)
  • Dentistry and Oral Medicine (219)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10326)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2652)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (680)
  • Hematology (269)
  • HIV/AIDS (570)
  • Infectious Diseases (except HIV/AIDS) (12116)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (274)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2478)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (496)
  • Occupational and Environmental Health (569)
  • Oncology (1332)
  • Ophthalmology (403)
  • Orthopedics (151)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (344)
  • Pediatrics (785)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2417)
  • Public and Global Health (5029)
  • Radiology and Imaging (900)
  • Rehabilitation Medicine and Physical Therapy (533)
  • Respiratory Medicine (687)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)